Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Respiratory Tract Infections » Sinusitis
Diseases [C] » Respiratory Tract Diseases [C08] » Nose Diseases » Paranasal Sinus Diseases » Sinusitis
Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Infections » Sinusitis
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Nose Diseases » Paranasal Sinus Diseases » Sinusitis
Description
Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES. MeSH
Hierarchy View
Subtype Terms (5)
Approved Indicated Drugs (17)
Phase 4 Indicated Drugs (37)
Phase 3 Indicated Drugs (23)
Phase 2 Indicated Drugs (19)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (16)
Organization Involved with Phase 4 Indications (54)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
Organization Involved with Phase 3 Indications (43)
Organization Involved with Phase 2 Indications (17)
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (21)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
